TRVI - Company ID 0001563880
As of 2026-11-07, Trevi Therapeutics, Inc. (TRVI) has a market capitalization of $2.03 B, making it the #2076 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-07 | $2.03 B |
| 2026-11-06 | $2.00 B |
| 2026-11-05 | $1.82 B |
| 2026-11-04 | $1.99 B |
| 2026-11-03 | $1.96 B |
| 2026-11-02 | $1.94 B |
| 2026-11-01 | $1.93 B |
| 2026-10-31 | $1.93 B |
| 2026-10-30 | $1.96 B |
| 2026-10-29 | $1.96 B |
| 2026-10-28 | $1.92 B |
| 2026-10-27 | $1.89 B |
As of 2026-11-07, Trevi Therapeutics, Inc. (TRVI) has a market capitalization of $2.03 B, making it the #2076 most valuable US-listed company.
Trevi Therapeutics, Inc. is the #2076 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-26 | $1.78 B |
| 2026-10-25 | $1.79 B |
| 2026-10-24 | $1.79 B |
| 2026-10-23 | $1.84 B |
| 2026-10-22 | $1.81 B |
| 2026-10-21 | $1.81 B |
| 2026-10-20 | $1.82 B |
| 2026-10-19 | $1.69 B |
| 2026-10-18 | $1.69 B |
| 2026-10-17 | $1.69 B |
| 2026-10-16 | $1.69 B |
| 2026-10-15 | $1.72 B |
| 2026-10-14 | $1.71 B |
| 2026-10-13 | $1.74 B |
| 2026-10-12 | $1.84 B |
| 2026-10-11 | $1.87 B |
| 2026-10-10 | $1.87 B |
| 2026-10-09 | $1.87 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.